|
|
|
| Technical aspects in pancreaticoduodenectomy and therapeutic strategies for pancreatic cancer: History, current status, and future perspectives |
| Tomohide Hori a , ∗, Daiki Yasukawa b |
a Department of Surgery, Shiga General Hospital, Moriyama 524-8524, Japan
b Department of Surgery, Shiga University of Medical Science, Otsu 520-2192, Japan
∗ Corresponding author.
E-mail address: horitomo55office@yahoo.co.jp (T. Hori). |
|
|
|
|
Abstract The incidence of pancreatic cancer (PC) has increased, and invasive ductal adenocarcinoma is the most common among PC patients [1]. Even in patients who receive radical treatments, namely chemotherapy and surgery, the five-year survival is only 2%-9% [1]. Currently, many physicians recognize that further developments in multidisciplinary therapy are crucial to overcome PC [1].
|
|
|
|
|
|
| [1] |
Li JH, Xu X, Wang YF, Xie HY, Chen JY, Dong NG, Badiwala M, Xin LM, Ribeiro RVP, Yin H, Zhang H, Zhang JZ, Huo F, Yang JY, Yang HJ, Pan H, Li SG, Qiao YB, Luo J, Tang PF, Ye QF, Zheng SS. Chinese expert consensus on organ protection of transplantation (2022 edition)[J]. Hepatobiliary Pancreat Dis Int, 2022, 21(6): 516-526. |
|
|
|
|
2022, Vol. 21 
